Curaleaf Holdings earned $0.03 in the first quarter, compared to $0.02 in the year-ago quarter. Since then, MCRB stock has increased by 895.1% and is now trading at $26.27. This press release features multimedia. View which … The current stock performance of Vonage Hldgs shows a 52-week-high of $13.66 and a 52-week-low of $4.18. Moreover, at the end of the last trading period, the closing price was at $26.55. MCRB is not currently paying a regular dividend. Let's conquer your financial goals together...faster. Get the latest Seres Therapeutics Inc MCRB detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Adverum Biotechnologies (ADVM) -16%. While stock picking isn't easy, for those willing to persist and learn, it is possible to buy shares in great... Upgrades * Wedbush upgraded the previous rating for Best Buy Co Inc (NYSE: BBY) from Neutral to Outperform. Moreover, at the end of the last trading period, the closing price was at $9.43. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. 26.49, 2.52 / For the second quarter, Intercontinental Exchange had an EPS of $1.07, compared to year-ago quarter EPS of $0.94. Montage Resources closed at $5.51 at the end of the last trading period. Seres Therapeutics' stock was trading at $2.64 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). After obtaining highly statistically significant topline Phase 3 ECOSPOR III SER-109 study results in recurrent CDI, Seres requested a Breakthrough Therapy Designation meeting with the FDA. * With a current rating of Overweight, Piper Sandler initiated coverage on ITeos Therapeutics Inc (NASDAQ: ITOS). MCRB | Complete Seres Therapeutics Inc. stock news by MarketWatch. * Needham initiated coverage on Personalis Inc (NASDAQ: PSNL) with a Buy rating. Just enter your email address below. AMAG Pharmaceuticals earned $0.57 in the second quarter, compared to $1.14 in the year-ago quarter. in Biotech. TheStreet Ratings updates stock ratings daily. MCRB earnings call for the period ending June 30, 2019. View detailed financial information, real-time news, videos, quotes and analysis on Seres Therapeutics Inc (NASDAQ:MCRB). In response to the meeting request, the FDA reaffirmed its prior guidance regarding the efficacy requirements to support a SER-109 BLA submission, which were exceeded by the recent positive SER-109 Phase 3 study results, reaffirmed its prior guidance that at ... Technavio has been monitoring the human microbiome therapeutics market and it is poised to grow by USD 276.93 mn during 2020-2024, progressing at a CAGR of almost 15% during the forecast period. * For Barings BDC Inc (NYSE: BB... Seres Therapeutics, Inc. today announced the closing of an underwritten public offering of 12,075,000 shares of its common stock. Sorrento Therapeutics (SRNE) +12%. Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced that management will present at two upcoming investor conferences: Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced that it has obtained correspondence from the Office of Vaccines Research and Review of the U.S. Food and Drug Administration (FDA) regarding the Company’s plans to submit a Biologics License Application (BLA) to support product approval of SER-109 for recurrent C. difficile infection (CDI). At the end of the last trading period, AMAG Pharmaceuticals closed at $10.89.